Dysport vs. Botox: Two Very Good Sedans With Slightly Different Trim

Two medication vials side by side on a clinic tray, comparing Dysport and Botox neuromodulators.

By Alexander E. Bonato, MD โ€” Board-Certified in Internal Medicine ยท Medically reviewed July, 2026.

TL;DR: Dysport and Botox are both botulinum toxin type A โ€” same basic mechanism, both effective, both well-tolerated. The real differences are subtle: their โ€œunitsโ€ are not interchangeable (a Dysport unit โ‰  a Botox unit), Dysport tends to kick in a touch faster, and the two are formulated differently. Neither is universally โ€œbetterโ€ โ€” the right pick depends on the area being treated, your goals, and, most of all, the person holding the syringe. Anyone selling one as flatly superior to the other is overselling.

I am the kind of person who will stand in a grocery aisle for eleven minutes comparing two nearly identical jars of pasta sauce, convinced one holds the secret to happiness, before buying the one I always buy. So I have deep, personal sympathy for anyone paralyzed at the โ€œDysport or Botox?โ€ fork in the road. The good news: unlike my sauce situation, this decision genuinely doesn't have a wrong answer.

I'm a board-certified physician (internal medicine by training) at Bonato MD Aesthetics in Medford, and this is one of the most common questions I get after explaining how neuromodulators actually work . So let's settle it โ€” honestly, without turning either brand into a hero or a villain.

They're More Alike Than Different

Start here, because it deflates most of the drama: both Dysport and Botox are the same active molecule โ€” botulinum toxin type A โ€” doing the same job. They temporarily block the nerve signal that tells a muscle to contract, so the dynamic wrinkle that muscle creates softens. Same mechanism, same category, comparable results, similar excellent safety record. If you get a good result from one, you'll almost certainly get a good result from the other.

So we're not comparing a sports car to a bicycle. We're comparing two very good sedans with slightly different trim.

The Differences That Actually Matter

โ—        Their units are NOT the same โ€” this is the big one. A โ€œunitโ€ of Dysport is measured and formulated differently than a unit of Botox, so the numbers don't convert one-to-one. This is why comparing โ€œI got 20 unitsโ€ between brands is meaningless, and why per-unit price comparisons are a trap (more on that below).

โ—        Formulation. At their standard approved doses, Dysport's formulation actually delivers a bit more of the active core neurotoxin than Botox does โ€” a difference that may play into how quickly each starts working and how long it lasts.

โ—        Onset. Both start within a few days, but Dysport often gets going a hair faster โ€” patients frequently notice the beginning of an effect around two days in.

โ—        Feel and spread. Clinicians often describe subtle differences in how each product settles into the tissue. Whether that's a meaningful, provable advantage is genuinely debated โ€” head-to-head data is limited, and there's no agreed-upon conversion between products. In practice it comes down to matching the product and dose to the specific muscle.

Notice what's not on that list: a knockout punch. The honest scientific position is that direct, apples-to-apples comparison between these products is hard, the differences are small, and technique matters more than the brand on the vial.

The โ€œDysport Is Cheaperโ€ Myth

You'll see this everywhere: โ€œDysport is cheaper per unit!โ€ It's technically true and completely misleading. Because a Dysport unit isn't equivalent to a Botox unit, you need more Dysport units to do the same job โ€” so the per-unit price tells you nothing about what you'll actually pay for a treated area. Compare the total cost to treat the area, not the sticker price per unit. A good clinic will quote you by the result, not by a number designed to look like a bargain.

So Which One Should You Get?

Here's my genuinely unexciting, honest answer: it depends, and either is usually a great choice. Broad, expressive areas may nudge toward one product; small, precise zones near delicate muscles may nudge toward another; and if you've had a fantastic experience with one before, there's rarely a reason to switch. The decision is best made in person, matching the product to your anatomy and goals โ€” not from a blog, and definitely not from whichever brand a med spa happens to be running a promo on this month.

Frequently Asked Questions

Can I switch from Botox to Dysport (or back)?

Yes, easily. There's no โ€œloyaltyโ€ requirement and no harm in switching. We'll just re-dose appropriately for whichever product we use, since the units don't transfer over.

Does one last longer than the other?

On standard dosing, their durations are broadly comparable โ€” roughly three to five months for both. Individual factors (your metabolism, muscle strength, dose) affect duration far more than the brand does.

Is one more likely to look โ€œfrozenโ€?

No โ€” โ€œfrozenโ€ is a dosing-and-placement outcome, not a brand feature. Either product, dosed conservatively and placed well, leaves you natural and expressive.

Let's Pick the Right One Together โ€” in Southern Oregon

You don't need to agonize in the metaphorical pasta aisle over this. Both are excellent; the win is in the assessment and the technique. At Bonato MD Aesthetics we treat patients from Medford, Ashland, and Grants Pass, and we'll recommend the product that fits your face and goals โ€” and quote you honestly by the area, not by a misleading per-unit number.

Book a consultation and we'll sort it out in about ten minutes.

References

1. Kaufman-Janette J, Cox SE, Dayan S, Joseph J. Botulinum toxin type A for glabellar frown lines: what impact of higher doses on outcomes? Toxins (Basel). 2021;13(7):494. https://doi.org/10.3390/toxins13070494

2. Satriyasa BK. Botulinum toxin (Botox) A for reducing the appearance of facial wrinkles: a literature review of clinical use and pharmacological aspect. Clin Cosmet Investig Dermatol. 2019;12:223โ€“228. https://doi.org/10.2147/CCID.S202919

Next
Next

How Dysport Works: Turning Down the Volume on One Overachieving Muscle